TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8665629

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1%
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.3%
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 44
Study: 1923397

Group type: EXPERIMENTAL
Intervention: Daily chlorhexidine rinsing (0.12% solution)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Weekly chlorhexidine rinsing (0.12% solution)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no rinsing)
Number of subjects: 42
Study: 6135029

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduction of CyA dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Demonstration of CyA in cytological specimens
Number of subjects: 0
Study: 31638006

Group type: EXPERIMENTAL
Intervention: Formative Objective Structured Clinical Examination (OSCE) in pediatric module with feedback
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard pediatric module (Control)
Number of subjects: 119
Study: 29023670

Group type: EXPERIMENTAL
Intervention: Tuning Peg algorithm
Number of subjects: 0
Study: 26995367

Group type: EXPERIMENTAL
Intervention: Rhythm control strategy
Number of subjects: 9542

Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 9542

Group type: COMPARATOR
Intervention: Long-term outcomes associated with AF
Number of subjects: 9542

Group type: EXPERIMENTAL
Intervention: Quality of life (QoL)
Number of subjects: 9542
Study: 26247960

Group type: COMPARATOR
Intervention: EPA + DHA supplementation (0-4 portions of oily fish/week, equivalent to 3.27 g EPA+DHA per portion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22658422

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Exercise echocardiography
Number of subjects: 70
Study: 20461803

Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged-release (mean dose 10 mg/d)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Levodopa (mean additional dose 284 mg/d)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged-release
Number of subjects: 208

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged-release and Levodopa
Number of subjects: 208
Study: 18815665

Group type: EXPERIMENTAL
Intervention: Amiodarone (AMD) treatment
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Amiodarone (AMD) treatment for more than 24 months
Number of subjects: 96
Study: 16249738

Group type: EXPERIMENTAL
Intervention: CsA‐ME (Neoral) with C2 monitoring
Number of subjects: 123
Study: 12152001

Group type: COMPARATOR
Intervention: Intracoronary infusion of rhVEGF(165) at a dose rate of 17 or 50 ng/kg/min for 20 minutes, followed by three 4-hour intravenous infusions on days 3, 6, and 9
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous infusion of rhVEGF(165)
Number of subjects: 0
Study: 10548998

Group type: EXPERIMENTAL
Intervention: Berliner Lebensqualitätsprofil (BELP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Short form of the Berliner Lebensqualitätprofil (BELP-KF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Satisfaction with psychopharmacological treatment
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Satisfaction with sexual life
Number of subjects: 36
Study: 8786016

Group type: EXPERIMENTAL
Intervention: ALA 1200 mg
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: ALA 600 mg
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: ALA 100 mg
Number of subjects: 328

Group type: COMPARATOR
Intervention: PLAC
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 328
Study: 2178667

Group type: EXPERIMENTAL
Intervention: Cisplatinum alone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Methotrexate alone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cisplatinum + 5-FU
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cisplatinum + methotrexate
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cisplatinum arms
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combination regimens (cisplatinum + methotrexate or cisplatinum + 5-FU)
Number of subjects: 200
Study: 7044467

Group type: EXPERIMENTAL
Intervention: lipid-lowering therapy by diet and drugs
Number of subjects: 24

Group type: COMPARATOR
Intervention: usual-care
Number of subjects: 24
Study: 30562710

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 0
Study: 28434467

Group type: EXPERIMENTAL
Intervention: Abdominal electroacupuncture for 6 weeks
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 440

Group type: COMPARATOR
Intervention: Sham groups (control)
Number of subjects: 440
Study: 25224684

Group type: EXPERIMENTAL
Intervention: Sonic nebulization (Pulmicort, 2 × 1 mg/4 mL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral route (Medrol, 32 mg/8 days ‐16 mg/4 days‐8 mg/4 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nasal spray (Rhinocort, 2 × 2 × 64 µg/nostril)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (sonic nebulization, oral, nasal spray)
Number of subjects: 30
Study: 24158342

Group type: EXPERIMENTAL
Intervention: Implant overdentures (IODs)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional relines
Number of subjects: 34
Study: 21659672

Group type: EXPERIMENTAL
Intervention: Performance‐contingent monetary incentive
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Video camera placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Video camera self‐presentation
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Audience
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined pressure
Number of subjects: 45

Group type: COMPARATOR
Intervention: Motivational pressure treatments
Number of subjects: 45
Study: 19298728

Group type: EXPERIMENTAL
Intervention: Microsurgical testicular sperm extraction (microTESE)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional TESE
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: FSH concentration > or = 3 x maximum value of normal range (N)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: 2N < or = FSH < 3N
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: N < FSH < 2N
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: FSH = N
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Volume (V) > or = 12 ml
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: 8 ml < or = V < 12 ml
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: V < 8 ml
Number of subjects: 138
Study: 20859313

Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine only (Group I)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine and steroid (Group II)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both groups (I and II)
Number of subjects: 120
Study: 15642059

Group type: EXPERIMENTAL
Intervention: Test toothpaste containing 0.3% triclosan, 5% potassium nitrate, and 0.76% sodium monofluorophosphate (SMFP)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control toothpaste containing 5% potassium nitrate and 0.76% SMFP
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Benchmark toothpaste containing only 0.76% SMFP
Number of subjects: 102
Study: 12394804

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 600
Study: 9987465

Group type: EXPERIMENTAL
Intervention: Worksite-plus-family intervention
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: Worksite intervention
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Minimal intervention control group
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Comparison of worksite-plus-family group to control group
Number of subjects: 1359
Study: 7484858

Group type: EXPERIMENTAL
Intervention: Intravenous dofetilide at doses of 3.0 to 15.0 micrograms/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous dofetilide at a dose of 1.5 micrograms/kg
Number of subjects: 50
Study: 2310104

Group type: EXPERIMENTAL
Intervention: Transtracheal oxygen delivery
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nasal cannula oxygen delivery
Number of subjects: 11
Study: 7022420

Group type: EXPERIMENTAL
Intervention: Prazosin 1 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31916229

Group type: EXPERIMENTAL
Intervention: Systemic inflammation (measured by serum CRP)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: LAVI (left atrial volume indexed to body surface area)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Longitudinal analysis using Mixed Linear Model
Number of subjects: 220
Study: 29987587

Group type: EXPERIMENTAL
Intervention: Bilateral botulinum toxin (BT) therapy using CBTX‐A, standard doses on affected side, one-third doses on non-affected side
Number of subjects: 43

Group type: COMPARATOR
Intervention: Unilateral botulinum toxin (BT) therapy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Bilateral botulinum toxin (BT) therapy
Number of subjects: 43
Study: 29444394

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (group S)
Number of subjects: 50

Group type: COMPARATOR
Intervention: General anesthesia (group G)
Number of subjects: 50
Study: 25200354

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2b 1.5μg/kg/wk for 48 weeks (arm C)
Number of subjects: 670

Group type: COMPARATOR
Intervention: PEG‐IFN alfa‐2b 1.0μg/kg/wk for 24 weeks (arm A)
Number of subjects: 670

Group type: COMPARATOR
Intervention: PEG‐IFN alfa‐2b 1.5μg/kg/wk for 24 weeks (arm B)
Number of subjects: 670
Study: 22733398

Group type: EXPERIMENTAL
Intervention: Triptorelin pamoate (TP) at a dose of 11.5 mg at 3-month intervals until documented progression
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Triptorelin pamoate (TP)
Number of subjects: 36
Study: 20496365

Group type: EXPERIMENTAL
Intervention: Milnacipran 100 mg/day
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1025
Study: 18389076

Group type: EXPERIMENTAL
Intervention: C-peptide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 16279146

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12496050

Group type: EXPERIMENTAL
Intervention: Strength training (15 weeks of supervised training followed by 6 months of unsupervised training)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 54
Study: 10515676

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 50 mg twice weekly associated with cyclic medroxyprogesterone acetate 10 mg daily (n = 10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Tibolone 2.5 mg administered orally once a day (n = 11)
Number of subjects: 21
Study: 7669823

Group type: EXPERIMENTAL
Intervention: Attacks by mentally ill individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-attack social attitudes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regional replication of public attitude change
Number of subjects: 0
Study: 2341686

Group type: EXPERIMENTAL
Intervention: Urinary sheath system with a specific leg-bag design
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hybrid urinary sheath system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Alternative urinary sheath systems
Number of subjects: 30
Study: 7451921

Group type: EXPERIMENTAL
Intervention: Severe esophagitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up motility studies 1 month after injury
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mild caustic esophagitis
Number of subjects: 0
Study: 31262319

Group type: EXPERIMENTAL
Intervention: Optical flow perturbation training (10 min treadmill walking with optical flow perturbations)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control session (10 min treadmill walking without optical flow perturbations)
Number of subjects: 13
Study: 30466421

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Waist Circumference (WC)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Waist to Hip Ratio (WHR)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Waist to Height Ratio (WHtR)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: BMI for metabolic syndrome markers (females)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: WC for metabolic syndrome markers (females)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: WHtR for metabolic syndrome markers (females)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: WHR for metabolic syndrome markers (females)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: BMI for metabolic syndrome markers (males)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: WC for metabolic syndrome markers (males)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: WHtR for metabolic syndrome markers (males)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: WHR for metabolic syndrome markers (males)
Number of subjects: 704
Study: 27157033

Group type: EXPERIMENTAL
Intervention: Concrete processing mode
Number of subjects: 50

Group type: COMPARATOR
Intervention: Abstract processing mode
Number of subjects: 50
Study: 24744082

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) intervention with inpatient introductory visit and weekly post‐discharge telephonic support for 4 weeks
Number of subjects: 423

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 423
Study: 22511036

Group type: EXPERIMENTAL
Intervention: 595 nM pulsed-dye laser (PDL) at pulse energy of 15 J/cm², 3-millisecond pulse length, 7-mm spot size, 10% overlap of pulses, two passes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 595 nM pulsed-dye laser (PDL) at pulse energy of 7.5 J/cm², 3-millisecond pulse length, 10-mm spot size, 10% overlap of pulses, double stacked pulses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study: 20447629

Group type: EXPERIMENTAL
Intervention: Microsurgical subinguinal varicocelectomy (MSSIV)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional, nonmagnified subinguinal varicocelectomy (NMSIV)
Number of subjects: 162
Study: 17964875

Group type: EXPERIMENTAL
Intervention: Synchronous peripheral nerve stimulation (PNS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Asynchronous PNS
Number of subjects: 9
Study: 16126049

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11392579

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9701421

Group type: EXPERIMENTAL
Intervention: levodropropizine (75 mg t.i.d.; 7 days)
Number of subjects: 140

Group type: COMPARATOR
Intervention: dihydrocodeine (10 mg t.i.d.; 7 days)
Number of subjects: 140
Study: 7913452

Group type: EXPERIMENTAL
Intervention: Educational intervention involving visits by a GP or pharmacist trained in communication skills, providing relaxation tapes and management guidelines.
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Self-rating of benzodiazepine prescribing by GPs.
Number of subjects: 137
Study: 2638619

Group type: EXPERIMENTAL
Intervention: Breast milk substitute with taurine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Breast milk substitute without taurine
Number of subjects: 20
Study: 31842860

Group type: EXPERIMENTAL
Intervention: Tianshu capsule (TSC) 4.08 g, three times daily
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 27370816

Group type: EXPERIMENTAL
Intervention: Artesunate
Number of subjects: 122

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 122
Study: 26044701

Group type: EXPERIMENTAL
Intervention: Intra-arterial injection of autologous bone marrow mononuclear cells (2×10^6/kg or 5×10^6/kg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Non-treated group
Number of subjects: 76
Study: 23808439

Group type: EXPERIMENTAL
Intervention: EG2 (4 PE sessions/week of high intensity)
Number of subjects: 67

Group type: COMPARATOR
Intervention: CG (usual PE in Spain, 2 sessions/week)
Number of subjects: 67
Study: 21653833

Group type: EXPERIMENTAL
Intervention: MOG(97‐109)‐reactive CD4(+) T cells isolated with DRB1*0401/MOG(97‐109) tetramers after culture with MOG(97‐109) peptides
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T cell clones from single cell cloning of DRB1*0401/MOG(97‐109(107E‐S)) tetramer(+) cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Class II tetramers used for detection
Number of subjects: 0

Group type: COMPARATOR
Intervention: MOG(97‐109)‐reactive T cells
Number of subjects: 0
Study: 19543851

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (etoposide and vincristine, combined with either carboplatin or cyclophosphamide)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observation (no chemotherapy)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Treatment (chemotherapy)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall clinical outcomes
Number of subjects: 30
Study: 16423676

Group type: EXPERIMENTAL
Intervention: Left bundle branch block (LBBB)
Number of subjects: 94
Study: 14996778

Group type: EXPERIMENTAL
Intervention: Neurolytic celiac plexus block (NCPB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Opioids alone (systemic analgesic therapy with a sham injection)
Number of subjects: 100
Study: 11737373

Group type: EXPERIMENTAL
Intervention: ABC + CART
Number of subjects: 185

Group type: COMPARATOR
Intervention: CART
Number of subjects: 185
Study: 9506654

Group type: EXPERIMENTAL
Intervention: 40 mg/kg phenobarbital intravenously over 1 hour
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no phenobarbital)
Number of subjects: 31
Study: 7802250

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 100
Study: 2902779

Group type: EXPERIMENTAL
Intervention: Nifedipine in patients with mixed angina
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nifedipine in patients with classic exertional angina
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo in patients with mixed angina
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo in patients with classic exertional angina
Number of subjects: 72
Study: 31963163

Group type: EXPERIMENTAL
Intervention: NALC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ALC
Number of subjects: 12
Study: 31362557

Group type: EXPERIMENTAL
Intervention: Immediate MRI of the wrist during the initial ED attendance
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no further imaging)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Immediate MRI of the wrist
Number of subjects: 132
Study: 28824296

Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 12

Group type: COMPARATOR
Intervention: Maltodextrin
Number of subjects: 12
Study: 25478956

Group type: EXPERIMENTAL
Intervention: Web-based intervention (Bounce Back Now)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 24348624

Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation applied for 30 seconds on one half of the maxillary and mandibular arches for 5 days.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (opposite half of the arches without laser irradiation).
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation.
Number of subjects: 29
Study: 21998656

Group type: EXPERIMENTAL
Intervention: Motor skill learning intervention
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 6
Study: 18438240

Group type: EXPERIMENTAL
Intervention: 6 sets of stretches (90 seconds per muscle group)
Number of subjects: 20
Study: 16931218

Group type: EXPERIMENTAL
Intervention: Once every 2 weeks subcutaneous epoetin beta (group 2w)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Once weekly subcutaneous epoetin beta (group 1w)
Number of subjects: 207
Study: 12297476

Group type: EXPERIMENTAL
Intervention: Nimodipine on the basis of conventional therapy lasting till 30 days after injuries
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional therapy including craniotomy, hemostasis, dehydration, anti-infection and corticosteroid administration
Number of subjects: 80
Study: 14528541

Group type: EXPERIMENTAL
Intervention: Arthritis presence
Number of subjects: 0
Study: 8672322

Group type: EXPERIMENTAL
Intervention: Flunitrazepam-clonidine
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Chlormethiazole-haloperidol
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Flunitrazepam-haloperidol
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 197
Study: 2263264

Group type: EXPERIMENTAL
Intervention: Combination of dimethylfumarate and different salts of monoethylfumarate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 39

Group type: COMPARATOR
Intervention: Octylhydrogen fumarate
Number of subjects: 39
Study: 512148

Group type: EXPERIMENTAL
Intervention: VMIP depression
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Somatic suggestion
Number of subjects: 60

Group type: COMPARATOR
Intervention: VMIP neutral
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self-devaluation
Number of subjects: 60

Group type: COMPARATOR
Intervention: VMIP elation
Number of subjects: 60
Study: 6602783

Group type: EXPERIMENTAL
Intervention: Bepridil (2 mg/kg, intravenous infusion)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30672251

Group type: EXPERIMENTAL
Intervention: Tiaoshen Acupuncture
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional acupuncture (Control)
Number of subjects: 98